C. Vanesa Díaz-García

DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification

C. Vanesa Díaz-García, Alba Agudo-López, Carlos Pérez‐Plasencia et al. · Carcinogenesis · 2013 · 50 citations · Full text

Risk factors associated with Clostridium difficile infection in adult oncology patients

Analia Rodríguez Garzotto, Antonio Garcia, Nerea Muñoz Unceta et al. · Supportive Care in Cancer · 2014 · 49 citations

Adult Oncology Patients, Health Sciences, Clostridium Difficile Infection +9

A Polycomb-mir200 loop regulates clinical outcome in bladder cancer

Mónica Martínez‐Fernández, Marta Dueñas, Andrew Feber et al. · Oncotarget · 2015 · 45 citations · Full text

Transcriptional Regulation, Urology, Mir-200 Family Members +11

Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients

M. Teresa Agulló-Ortuño, Inmaculada García‐Ruiz, C. Vanesa Díaz-García et al. · Cancer Chemotherapy and Pharmacology · 2019 · 28 citations

Prognostic Biomarkers, Potential Predictive Biomarkers, Medicine +9

Evaluation of novel trans-sulfonamide platinum complexes against tumor cell lines

Carlos Pérez‐Plasencia, C. Vanesa Díaz-García, Alba Agudo-López et al. · European Journal of Medicinal Chemistry · 2014 · 27 citations

Nanomedicine, Medicinal Chemistry, Polymer-drug Conjugate +12